← Leaderboards
William R Clarke
Xlock Biosciences, Llc
$1,242,017
Attributed
$2,224,420
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $998.6K · FY2022–24$1M$750K$500K$250K$0
'22
'23
'24
Funding mix
By agency
NIH$2,224,420 · 2
By mechanism
R44$1,964,807 · 1
R43$259,613 · 1
Top collaborators
- Brian F Volkman2 shared
Most similar at Xlock Biosciences, Llc
Same institution · by research overlap
- Chad Allen Koplinski$842,940
Others in their field
Other Rising Stars on “Engineering”
- Nancy Jean Sullivan · Boston University Medical Campus$34,500,000
- Cyrus Wadia · Activate Global, Inc.$31,489,493
- Tim A Bertram · Wake Forest University School Of Medicine$30,163,580
- Rashada Alexander · American Association For The Advancement Of Science$22,676,040
- Jonathan H Elias · Association Of Universities For Research In Astronomy, Inc.$16,042,279
- Michael Hogarth · University Of California, San Diego$14,390,863
Research focus
EngineeringGenerationsDoseEffective TherapyExperimental StudyFormulationDimerDisease ModelAntibodiesDrug DevelopmentChemokineClinical TrialsAutoimmune DiseasesFirst-In-HumanAnimal ModelCellsBiochemicalBiologicalBiological Response Modifier TherapyBiological SciencesCcl20 GeneCcr6 GeneAffectG-Protein-Coupled Receptors
Grant awards (3)
Targeting the CCR6-CCL20 pathway for treatment of psoriatic joint and entheseal inflammation$966,201
R44 · FY2024 · AR · contact PI
Targeting the CCR6-CCL20 pathway for treatment of psoriatic joint and entheseal inflammation$998,606
R44 · FY2023 · AR · contact PI
Development of an engineered CCL20 as a therapeutic molecule for chronic graft-versus-host disease$259,613
R43 · FY2022 · HL · contact PI